MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$12,150K
Net Income
-$94,442K
Net Profit Margin
-777.30%
EPS
-$1.26
Unit: Thousand (K) dollars
Revenue Breakdown
Total revenue from contracts wit...
Total revenue from contracts wit...
Revenue Breakdown
Incyte
Gilead
Partner Therapeutics License Agr...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-03-31
2024-12-31
2024-09-30
Total revenue
12,150
26,488
817
11,772
Research and development
80,017
80,116
35,651*
63,239
General and administrative
28,611
22,112
20,537*
20,765
Total operating expenses
108,628
102,228
56,188
84,004
Operating loss
-96,478
-75,740
-55,371*
-72,232
Other expense
-
1,766
-
-
Interest income, net
8,827
7,203
27*
10,254
Foreign exchange loss
-2,172
-24,316
138,953*
-34,950
Other income (expense)
119
-
-
-
Total other income (loss), net
6,774
-18,879
138,980*
-24,696
Net gain before income taxes
-89,704
-94,619
83,609*
-96,928
Income tax expense
5,816
1,855
-780*
2,977
Net gain
-95,520
-96,474
84,389*
-99,905
Currency translation adjustment
1,078
23,105
-128,257*
31,775
Comprehensive loss
-94,442
-73,369
-43,868
-68,130
Basic EPS
-1.26
-1.4
-0.729
-1.46
Diluted EPS
-1.26
-1.4
-0.729
-1.46
Basic Average Shares
75,675,631
69,017,576
60,187,410
68,254,120
Diluted Average Shares
75,675,631
69,017,576
60,187,410
68,254,120
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Comprehensive loss
-$94,442K
(-38.62%↓ Y/Y)
Currency translation
adjustment
$1,078K
(-96.61%↓ Y/Y)
Net gain
-$95,520K
(4.39%↑ Y/Y)
Interest income, net
$8,827K
(-13.92%↓ Y/Y)
Other income
(expense)
$119K
Net gain before
income taxes
-$89,704K
(7.45%↑ Y/Y)
Income tax expense
$5,816K
(95.36%↑ Y/Y)
Total other income
(loss), net
$6,774K
(127.43%↑ Y/Y)
Total revenue from
contracts with...
$11,867K
Total revenue from
contracts with...
$283K
Foreign exchange loss
-$2,172K
(93.79%↑ Y/Y)
Operating loss
-$96,478K
(-33.57%↓ Y/Y)
Total revenue
$12,150K
(3.21%↑ Y/Y)
Total operating
expenses
$108,628K
(29.31%↑ Y/Y)
Research and development
$80,017K
(26.53%↑ Y/Y)
General and
administrative
$28,611K
(37.78%↑ Y/Y)
Buy us a coffee
Merus N.V. (MRUS)
Merus N.V. (MRUS)